Journal
ENVIRONMENTAL TOXICOLOGY
Volume 35, Issue 10, Pages 1058-1069Publisher
WILEY
DOI: 10.1002/tox.22942
Keywords
EGFR; ERK; glioblastoma; hyperforin; NF-kappa B
Categories
Funding
- Zuoying Branch of Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan [ZBH108-24]
- China Medical University, Taiwan [CMU108-N-06]
- Ministry of Science and Technology, Taiwan [MOST 107-2314-B-039-068-MY2, MOST 108-2314-B-039-007-MY3]
- Show Chwan Memorial Hospital, Changhua, Taiwan [RD-108022]
Ask authors/readers for more resources
Glioblastoma is the most common primary brain tumor with poor survival rate and without effective treatment strategy. Notably, amplification and active mutation of epidermal growth factor receptor (EGFR) occur frequently in glioblastoma patient that may be a potential treatment target. Several studies indicated that various type of herbal compounds not only regulate anti-depressant effect but also shown capacity to suppress glioblastoma growth via inducing apoptosis and inhibiting oncogene signaling transduction. Hyperforin, an herb compound derived from St. John's wort was used to treat depressive disorder by inhibiting neuronal reuptake of several neurotransmitters. Although hyperforin can reduce matrix metallopeptidases-2 (MMPs) and -9-mediated metastasis of glioblastoma, the detail mechanism of hyperforin on glioblastoma is remaining unclear. Here, we suggested that hyperforin may induce extrinsic/intrinsic apoptosis and suppress anti-apoptotic related proteins expression of glioblastoma. We also indicated that hyperforin-mediated anti-apoptotic potential of glioblastoma was correlated to inactivation of EGFR/extracellular signal-regulated kinases (ERK)/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) signaling.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available